T. Rowe Price Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8M | Sell |
3,261,218
-55,951
| -2% | -$409K | 0.02% | 483 |
|
|
2025
Q1 | $31.5M | Sell |
3,317,169
-3,210,942
| -49% | -$30.5M | 0.02% | 465 |
|
|
2024
Q4 | $108M | Sell |
6,528,111
-13,289
| -0.2% | -$219K | 0.07% | 280 |
|
|
2024
Q3 | $96.5M | Sell |
6,541,400
-188,883
| -3% | -$2.79M | 0.06% | 301 |
|
|
2024
Q2 | $93.4M | Sell |
6,730,283
-127,298
| -2% | -$1.77M | 0.06% | 297 |
|
|
2024
Q1 | $108M | Buy |
6,857,581
+475,066
| +7% | +$7.47M | 0.07% | 280 |
|
|
2023
Q4 | $103M | Buy |
6,382,515
+856,296
| +15% | +$13.9M | 0.07% | 270 |
|
|
2023
Q3 | $68M | Buy |
5,526,219
+466,633
| +9% | +$5.74M | 0.05% | 317 |
|
|
2023
Q2 | $81.3M | Buy |
5,059,586
+158,146
| +3% | +$2.54M | 0.06% | 297 |
|
|
2023
Q1 | $85.3M | Buy |
4,901,440
+1,984,505
| +68% | +$34.6M | 0.06% | 286 |
|
|
2022
Q4 | $27M | Buy |
2,916,935
+348,026
| +14% | +$3.22M | 0.02% | 428 |
|
|
2022
Q3 | $22.1M | Buy |
+2,568,909
| New | +$22.1M | 0.02% | 441 |
|